3470 results for «2025年12月MSCI美国50和标普500配置策略»
3470 results
Tricuspid Valve sessions from PCR London Valves 2025: Abbott
26 Nov 2025
Watch these recordings from PCR London Valves 2025 and EuroPCR 2025 on tricuspid valve.
Mitral session from PCR London Valves 2025: Abbott
26 Nov 2025
Watch these recordings from PCR London Valves 2025 and EuroPCR 2025 on Mitral.
The 2023 top Japanese abstracts
18 Feb 2023 – From PCR Tokyo Valves 2023
Explore the cutting-edge research showcased in the top Japenese abstracts of PCR Tokyo Valves 2023. Uncover profound insights, including a detailed examination of three-year outcomes in 500 patients treated with MitraClip, a comparative analysis of outcomes between COMBO therapy and transcatheter edge-to-edge repair for severe mitral...
GulfPCR-GIM 2025: the Training Programme is now available!
Tricuspid valve: PCR London Valves 2025 highlights
18 Nov 2025 – From PCR London Valves 2025
At PCR London Valves 2025, Course Directors Francesco Maisano and Nicolo Piazza highlight with Chris Allen the rapid evolution of tricuspid interventions. They emphasise advances in imaging and simulation, with dedicated labs offering practical multimodality training and hands-on experience. LIVE cases showcased both repair and replacement...
Mitral valve: PCR London Valves 2025 highlights
17 Nov 2025 – From PCR London Valves 2025
Together with Chris Allen, Course Directors Tiffany Patterson and Nina Wunderlich highlight the Mitral programme from PCR London Valves 2025. The Course began with fundamentals, including imaging and step-by-step procedural training, and then focused on complex cases, complications, and hands-on discussions. LIVE cases featured edge-to-edge repair,...
PCR Tokyo Valves 2025: Dive into the Scientific Programme!
Aortic valve: PCR London Valves 2025 highlights
17 Nov 2025 – From PCR London Valves 2025
At PCR London Valves 2025, Chris Cook speaks with Course Directors Bernard Prendergast and Simon Redwood about the main highlights from the aortic track. They underline the growing focus on lifetime management, including valve choice, future coronary access, durability, and new long-term data supporting TAVI in...
Highlights of science and education in cardiovascular interventional medicine in 2025
22 Dec 2025
Dear Colleagues, dear PCR Companions,
As we welcome a New Year, it is the perfect time to reflect on what we achieved together over the past year - both as a celebration of our collective success and as motivation to continue improving in the year ahead.
2025 was...
Structural and Valvular Interventions: EuroPCR 2025 highlights
22 May 2025 – From EuroPCR 2025
Christopher Cook, Nicolas Dumonteil, and Bernard Prendergast share their top EuroPCR 2025 highlights in structural heart interventions. Challenging cases like re-do TAVI, coronary re-access difficulties, and leaflet modification took center stage in case-based and LIVE sessions. Cutting-edge research was featured too, including a meta-analysis combining the...
Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies
21 May 2025 – From EuroPCR 2025
Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...
Latest clinical evidence on intravascular lithotripsy from EuroPCR 2025
20 May 2025 – From EuroPCR 2025
In this #europcr 2025 roundtable, Niels Thue Olsen and Margaret McEntegart discuss with Flavio Luciano Ribichini the latest data on intravascular lithotripsy (IVL), based on two pivotal studies.
- EMPOWER CAD: the first prospective, real-world PCI trial dedicated to women with complex, calcified coronary artery disease. With an IVL-first strategy...
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
Watch the interview with Fabien...
Learning from lived experience and contemporary evidence: shaping the treatment of women with heart valve disease
17 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of the lived experiences of women with valvular heart disease, emphasizing the unique challenges in detection, diagnosis, treatment, and follow-up. It integrates contemporary evidence and the forthcoming 2025 ESC/EACTS guidelines to offer practice-ready strategies tailored to the management of valvular...
FAITAVI - Major Late-Breaking Trial from EuroPCR 2025
22 May 2025 – From EuroPCR 2025
Presented at EuroPCR 2025, the FAITAVI trial brings new insights into the management of coronary artery disease in patients undergoing TAVI.
In this PCR Perspectives video, Stephan Windecker and Flavio Ribichini explore how the trial—the first of its kind—compared angiography-guided versus FFR-guided strategies for intermediate coronary lesions....
Future devices for structural heart interventions
08 Feb 2025 – From PCR Tokyo Valves 2025
Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.
EuroPCR 2025: innovation, clinical trials and education
11 Jun 2025
Discover what D. Milasinovic and A. Latib shared on the takeaways of EuroPCR 2025.
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
Highlights in valvular heart disease research - The year in EuroIntervention
17 Nov 2025 – From PCR London Valves 2025
This session highlights the most impactful research in valvular heart disease published in EuroIntervention in 2025. It reviews pivotal studies such as the ASCoP registry on complex PCI in severe aortic stenosis, the LANDMARK trial comparing Myval THV to other valves, and the D-PACE scoring system...
